Acknowledgement
This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (NRF-2017R1D1A1B03034904) (2020R1C1C1008675), and by Korea Institute of Planning and Evaluation for Technology in Food, Agriculture and Forestry (IPET) through Companion Animal Life Cycle Industry Technology Development Program, funded by Ministry of Agriculture, Food and Rural Affairs (MAFRA) (322092-04-1-HD030).
References
- Bailey DB. Paraneoplastic syndromes. In: Vail DM, Thamm DH, Liptak J, editors. Withrow and MacEwen's small animal clinical oncology. 6th ed. Philadelphia: Elsevier Health Sciences. 2020: 98-112.
- Boral BM, Williams DJ, Boral LI. Disseminated intravascular coagulation. Am J Clin Pathol 2016; 146: 670-680. https://doi.org/10.1093/ajcp/aqw195
- de M Souza CH, Toledo-Piza E, Amorin R, Barboza A, Tobias KM. Inflammatory mammary carcinoma in 12 dogs: clinical features, cyclooxygenase-2 expression, and response to piroxicam treatment. Can Vet J 2009; 50: 506-510.
- Duda NCB, Valle SF, Matheus JP, Angeli NC, Vieira LC, Oliveira LO, et al. Paraneoplastic hematological, biochemical, and hemostatic abnormalities in female dogs with mammary neoplasms. Pesq Vet Bras 2017; 37: 479-484. https://doi.org/10.1590/s0100-736x2017000500009
- Hunt BJ. Bleeding and coagulopathies in critical care. N Engl J Med 2014; 370: 847-859. https://doi.org/10.1056/NEJMra1208626
- Kristensen AT, Wiinberg B, Jessen LR, Andreasen E, Jensen AL. Evaluation of human recombinant tissue factor-activated thromboelastography in 49 dogs with neoplasia. J Vet Intern Med 2008; 22: 140-147. https://doi.org/10.1111/j.1939-1676.2008.0030.x
- Lallo MA, Ferrarias TM, Stravino A, Rodriguez JFM, Zucare RLC. Hematologic abnormalities in dogs bearing mammary tumor. R Bras Ci Vet 2016; 23: 3-8. https://doi.org/10.4322/rbcv.2016.020
- Marconato L, Romanelli G, Stefanello D, Giacoboni C, Bonfanti U, Bettini G, et al. Prognostic factors for dogs with mammary inflammatory carcinoma: 43 cases (2003-2008). J Am Vet Med Assoc 2009; 235: 967-972. https://doi.org/10.2460/javma.235.8.967
- Maruyama H, Miura T, Sakai M, Koie H, Yamaya Y, Shibuya H, et al. The incidence of disseminated intravascular coagulation in dogs with malignant tumor. J Vet Med Sci 2004; 66: 573-575. https://doi.org/10.1292/jvms.66.573
- Oliveira MR, Carneiro RA, Nunes FC, Teixeira SV, Vieira TC, Lavalle GE, et al. Hematological and biochemical alterations in female dogs with mammary cancer and inflammatory carcinoma. Arq Bras Med Vet Zootec 2022; 74: 428-436. https://doi.org/10.1590/1678-4162-12471
- Papageorgiou C, Jourdi G, Adjambri E, Walborn A, Patel P, Fareed J, et al. Disseminated intravascular coagulation: an update on pathogenesis, diagnosis, and therapeutic strategies. Clin Appl Thromb Hemost 2018; 24(9_suppl): 8S-28S. https://doi.org/10.1177/1076029618806424
- Singletary SE, Cristofanilli M. Defining the clinical diagnosis of inflammatory breast cancer. Semin Oncol 2008; 35: 7-10. https://doi.org/10.1053/j.seminoncol.2007.11.010
- Stockhaus C, Kohn B, Rudolph R, Brunnberg L, Giger U. Correlation of haemostatic abnormalities with tumour stage and characteristics in dogs with mammary carcinoma. J Small Anim Pract 1999; 40: 326-331. https://doi.org/10.1111/j.1748-5827.1999.tb03090.x